HUMAN PAPILLOMAVIRUS INFECTION VACCINES MARKET ANALYSIS

Name: Human Papillomavirus Infection Vaccines Market Regional Analysis
Creator: Coherent Market Insights
License: https://www.coherentmarketinsights.com/privacy-policy

Human Papillomavirus Infection Vaccines Market by Product (Gardasil, Gardasil 9, Cervarix and Other Vaccines), by End Users (Hospital, Clinics, Healthcare Centers, and Others) and by Region - Global Industry Insights, Trends, Outlook and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI1588
Formats :
Excel and PDF
Industry : Biotechnology

Regional Analysis

Human Papillomavirus (HPV) Infection Vaccines Market Regional Analysis

Regional segmentation of human papillomavirus (HPV) infection vaccine market by Coherent Market Insights, includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America comprises major share of the human papillomavirus infection treatment vaccine market, owing to high prevalence of cervical cancer, local market players and increasing governmental initiatives, followed by Europe. For instance, according to WHO 2016, currently 86% of America and 62% of European region girls have access to free HPV vaccination. Moreover, incidence of cervical cancer in Europe was 58,348 individuals per million in 2012. However, Asia Pacific is expected to witness significant growth during forecast period, due to awareness among the population for immunization.